Probably the easiest way to determine the full lenght will be to sequence the product you have and/or clone it, then sequence.
However, just found this paper:
Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses
J. Pinilla-Ibarz, K. Cathcart,T. Korontsvit,S. Soignet,M. Bocchia,J. Caggiano,L. Lai,J. Jimenez,J. Kolitz, andD. A. Scheinberg
Which contains the following paragraph (second one in the paper, immdeiately following the abstract, bolding mine):
"Chronic myeloid leukemia (CML) is a pluripotent stem cell disorder characterized by the presence of the Philadelphia chromosome (Ph1). Ph1 is the result of a translocation of the c-abl oncogene from chromosome 9 to the breakpoint cluster region (bcr), within the bcr gene on chromosome 22, forming a chimeric bcr-abl gene.1-3 The fused genes encode an 8.5-kb chimeric mRNA that is translated to a 210-kd protein.4-6 This p210 bcr-abl protein shows tyrosine kinase activity, is present in the leukemia cells of patients with CML, and is necessary and sufficient for transformation.7 In 95% of patients, the breakpoint in the bcr gene occurs either between bcr exon 2 (b2) and 3 (b3) or between bcr exon 3 (b3) and 4 (b4). Hence, 2 alternative chimeric p210 bcr-abl proteins, comprising either a b3a2 or a b2a2 junction, can result from this fusion gene.8"
de ifz
Member Since 08 May 2011Offline Last Active Feb 14 2013 03:25 AM





Find content
Not Telling
